Aline Baldo

868 total citations
21 papers, 657 citations indexed

About

Aline Baldo is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Aline Baldo has authored 21 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 10 papers in Infectious Diseases and 8 papers in Molecular Biology. Recurrent topics in Aline Baldo's work include Nail Diseases and Treatments (12 papers), Antifungal resistance and susceptibility (7 papers) and Fungal Infections and Studies (6 papers). Aline Baldo is often cited by papers focused on Nail Diseases and Treatments (12 papers), Antifungal resistance and susceptibility (7 papers) and Fungal Infections and Studies (6 papers). Aline Baldo collaborates with scholars based in Belgium, Romania and Spain. Aline Baldo's co-authors include Bernard Mignon, Anne Mathy, S. Vermout, Jérémy Tabart, Bertrand Losson, Bertrand Losson, Katia Pauwels, Ludivine Cambier, Nadine Antoine and Filip Lim and has published in prestigious journals such as British Journal of Dermatology, Veterinary Microbiology and FEMS Microbiology Letters.

In The Last Decade

Aline Baldo

21 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aline Baldo Belgium 13 472 230 165 116 87 21 657
Katia Jaton‐Ogay Switzerland 12 173 0.4× 55 0.2× 315 1.9× 200 1.7× 10 0.1× 17 736
Thomas D. Sullivan United States 16 308 0.7× 97 0.4× 236 1.4× 246 2.1× 7 0.1× 24 680
Sandra Bruns Germany 5 182 0.4× 39 0.2× 309 1.9× 184 1.6× 6 0.1× 6 582
D. R. Hewish Australia 12 108 0.2× 58 0.3× 108 0.7× 321 2.8× 9 0.1× 22 666
Peggy J. Rooney United States 10 194 0.4× 51 0.2× 104 0.6× 155 1.3× 5 0.1× 16 385
Ruchi Bhabhra United States 9 176 0.4× 82 0.4× 217 1.3× 271 2.3× 2 0.0× 17 627
Zhongsheng Tong China 11 211 0.4× 77 0.3× 141 0.9× 80 0.7× 8 0.1× 23 357
Yahui Guo China 10 148 0.3× 44 0.2× 185 1.1× 185 1.6× 4 0.0× 13 573
Pauline Verlhac France 11 322 0.7× 81 0.4× 62 0.4× 131 1.1× 2 0.0× 19 460

Countries citing papers authored by Aline Baldo

Since Specialization
Citations

This map shows the geographic impact of Aline Baldo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aline Baldo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aline Baldo more than expected).

Fields of papers citing papers by Aline Baldo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aline Baldo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aline Baldo. The network helps show where Aline Baldo may publish in the future.

Co-authorship network of co-authors of Aline Baldo

This figure shows the co-authorship network connecting the top 25 collaborators of Aline Baldo. A scholar is included among the top collaborators of Aline Baldo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aline Baldo. Aline Baldo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baldo, Aline, et al.. (2023). Oncolytic Viruses: An Inventory of Shedding Data from Clinical Trials and Elements for the Environmental Risk Assessment. Vaccines. 11(9). 1448–1448. 6 indexed citations
2.
Baldo, Aline, et al.. (2021). Environmental Risk Assessment of Recombinant Viral Vector Vaccines against SARS-Cov-2. Vaccines. 9(5). 453–453. 18 indexed citations
3.
Baldo, Aline, Evanthia Galanis, Frédéric Tangy, & Philippe Herman. (2015). Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination. Human Vaccines & Immunotherapeutics. 12(5). 1102–1116. 35 indexed citations
4.
Lim, Filip, et al.. (2014). Biosafety of Gene Therapy Vectors Derived From Herpes Simplex Virus Type 1. Current Gene Therapy. 13(6). 478–491. 15 indexed citations
5.
Baldo, Aline, et al.. (2014). Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety Considerations. Vaccines. 2(2). 463–499. 4 indexed citations
6.
Baldo, Aline, et al.. (2014). General Considerations on the Biosafety of Virus-derived Vectors Used in Gene Therapy and Vaccination. Current Gene Therapy. 13(6). 385–394. 58 indexed citations
7.
Baldo, Aline, et al.. (2013). Biosafety Risk Assessment and Management of Laboratory-Derived Influenza A (H5N1) Viruses Transmissible in Ferrets. Applied Biosafety. 18(1). 6–17. 2 indexed citations
8.
Baldo, Aline, et al.. (2013). Laboratory activities involving transmissible spongiform encephalopathy causing agents. Prion. 7(5). 420–433. 6 indexed citations
10.
Baldo, Aline, Anne Mathy, Ludivine Cambier, et al.. (2012). Subtilisin Sub3 is involved in adherence of Microsporum canis to human and animal epidermis. Veterinary Microbiology. 160(3-4). 413–419. 29 indexed citations
11.
Cambier, Ludivine, Anne Mathy, Aline Baldo, et al.. (2012). Feline polymorphonuclear neutrophils produce pro-inflammatory cytokines following exposure to Microsporum canis. Veterinary Microbiology. 162(2-4). 800–805. 11 indexed citations
12.
Baldo, Aline, Michel Monod, Anne Mathy, et al.. (2011). Mechanisms of skin adherence and invasion by dermatophytes. Mycoses. 55(3). 218–223. 82 indexed citations
13.
Mathy, Anne, Aline Baldo, Liliane Schoofs, et al.. (2010). Fungalysin and dipeptidyl-peptidase gene transcription in Microsporum canis strains isolated from symptomatic and asymptomatic cats. Veterinary Microbiology. 146(1-2). 179–182. 12 indexed citations
14.
Baldo, Aline, Anne Mathy, Jessica Tabart, et al.. (2009). Secreted subtilisin Sub3 from Microsporum canis is required for adherence to but not for invasion of the epidermis. British Journal of Dermatology. 162(5). 990–997. 55 indexed citations
15.
Vermout, S., Jérémy Tabart, Aline Baldo, et al.. (2008). Pathogenesis of Dermatophytosis. Mycopathologia. 166(5-6). 267–275. 154 indexed citations
16.
Mignon, Bernard, Jérémy Tabart, Aline Baldo, et al.. (2008). Immunization and dermatophytes. Current Opinion in Infectious Diseases. 21(2). 134–140. 36 indexed citations
17.
Tabart, Jérémy, Aline Baldo, S. Vermout, Bertrand Losson, & Bernard Mignon. (2008). Reconstructed interfollicular feline epidermis as a model for the screening of antifungal drugs againstMicrosporum canis. Veterinary Dermatology. 19(3). 130–133. 8 indexed citations
18.
Vermout, S., Aline Baldo, Jérémy Tabart, Bertrand Losson, & Bernard Mignon. (2008). Secreted dipeptidyl peptidases as potential virulence factors forMicrosporum canis. FEMS Immunology & Medical Microbiology. 54(3). 299–308. 25 indexed citations
19.
Vermout, S., et al.. (2007). RNA silencing in the dermatophyteMicrosporum canis. FEMS Microbiology Letters. 275(1). 38–45. 19 indexed citations
20.
Tabart, Jérémy, Aline Baldo, S. Vermout, et al.. (2007). Reconstructed interfollicular feline epidermis as a model for Microsporum canis dermatophytosis. Journal of Medical Microbiology. 56(7). 971–975. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026